Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VICI vs GSK✓SelectedUSD · GSKVICI vs GSK performance historyLatest closeAs of+0.04%11/20
Stock and ETF performance explorer

VICI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+93.6%
GSK return
+99.0%
Excess return
-5.4%
Maximum drawdown
-60.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D0.0%-0.1%+0.2%+0.1%
7D-3.2%-5.3%+2.1%-0.9%
30D+4.5%-3.7%+8.2%+6.2%
3M-7.2%-7.3%+0.1%-4.3%
6M-11.7%-4.2%-7.5%-10.4%
YTD-9.4%+0.9%-10.2%-10.8%
1Y-10.1%+7.3%-17.4%-14.0%
3Y+1.1%+52.7%-51.6%-21.8%
5Y+12.3%+40.1%-27.8%-11.6%
All+93.6%+99.0%-5.4%+32.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling